DOCSLIB.ORG

Mining the Microbiome to Modulate Host Defense Against Clostridioides Difficile Infections

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Mining the Microbiome to Modulate Host Defense Against Clostridioides difficile Infections Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades einer Doktorin der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Nathiana Smit aus Haarlem, Niederlande 1. Referent: Prof. Dr. Dieter Jahn 2. Referent: Prof. Dr. Till Strowig eingereicht am: 18-12-2019 mündliche Prüfung (Disputation) am: 01-09-2020 Druckjahr 2020 II Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für Lebenswissenschaften, vertreten durch den Mentor der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Publikationen Lagkouvardos, I., Lesker, T.R., Hitch, T.C.A., Gálvez, E.J.C., Smit, N., Neuhaus, K., Wang, J., Bained, J.F., Abt, B., Stecher, B., Overmann, J., Strowig, T., Clavel, T.: Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome 7: 28 (2019). doi:10.1186/s40168-019-0637-2 Ünal C.M., Berges, M., Smit, N., Schiene-Fischer, C., Priebe C., Strowig, T., Jahn, D., Steinert, M.: PrsA2 (CD630_35000) of Clostridioides difficile is an active parvulin-type PPIase and a virulence modulator. Frontiers of Microbiology 9: 2913 (2018). doi: 10.3389/fmicb.2018.02913 Tagungsbeiträge Smit, N., Lesker, TR., Kirstein, S., Neumann-Schaal, M., Stecher, B., Clavel, T., Strowig, T.: Exploring Oligo-MM12 mice to study precision microbiome reconstitution against Clostridium difficile infections. (Presentation). Vortragstagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie, Bochum, Deutschland (2018). Posterbeiträge Smit, N., Lesker, TR., Kirstein, S., Neumann-Schaal, M., Stecher, B., Clavel, T., Strowig, T.: Exploring Oligo-MM mice to study precision microbiome reconstitution against Clostridioides difficile infections. (Poster) 12. Vortragstagung der Clostpath 11, Leiden, Netherlands (2019). III IV Acknowledgements The previous four years I have been working on my PhD research. However, I could not have completed it without the help and support of a lot of people, friends and family. In this section I would like to show my gratitude and appreciation to all of those who made it possible for me to finish this thesis. To start, I would like to thank my supervisor, Prof. Dr. Till Strowig, for giving me the opportunity to conduct my research and to learn and work in the exciting field of microbiology and microbiota research. I am grateful for his help and support throughout my PhD studies, and his guidance that made the completion of this thesis possible. Additionally I would like to thank Prof. Dr. Dieter Jahn for agreeing to be my mentor and both members of my thesis committee, Prof. Dr. Petra Dersch and Dr. Matthias Lochner, for their time, valuable insights, suggestions to continue my work and to improve my research project. I also want to thank Prof. Dr. Stefan Dübel for agreeing to chair my disputation. My work would not have been possible without the support of numerous colleagues and collaborations. Most importantly I would like to thank the staff of the animal facility and the genome analytics core facility of the HZI, and additionally the help and advice of Dr. Meina Neumann-Schaal and Dr. Kerstin Schmidt-Hohagen concerning bile acids. Another thanks goes to the colleagues within the CDIFF consortium. I also would like to acknowledge my past and current colleagues from the MIKI group, not only for support and help during the work hours, but also next to work, for all the fun moments and enjoyable events we shared during the past years. However, a special thank you goes to Till Robin Lesker, who helped me analyze a lot of different data. I also want to thank Sophie Thiemann, who was my former supervisor during my Master thesis and the reason I got interested in microbiota research in the first place and why I started my PhD here at the HZI. In the time I was living in Braunschweig, I had the pleasure to meet and become friends with numerous people. I have learned so much new things next to learning about the microbiota, infections and C. difficile. During these years, I learned how to do scuba diving, climbing, bouldering and salsa dancing. I specifically want to name Tanya, Lisa, Simon, Charlotte and Richard for making my life great! V I also don’t want to forget to thank the friends I still have in the Netherlands (and Belgium): Evelien, Hilde, Amy, Serena and Jayron. Thank you for not forgetting about me, you are the best! I want to thank my family for their love and support during my life, including the time I spend performing my PhD. A thank you to my parents: my mom, Remco and my dad, who always believed I could do it, even in times I did not believe it myself and Remco for helping and instructing me in fields I was unfamiliar with. I also want to thank my grandparents for always being there for me and for always supporting me. Another thank you goes to Yoran and Glenn, my two “little” brothers for being in my life. And a special thank you goes to Ronald and Pauline who were always willing to drive back and forth for me! Last but definitely not least: a very special thank you and a lot of appreciation and gratitude goes to Jan-Maarten, who listened to me, supported me, believed in me, encouraged me and was at my side during the hardest parts of this thesis. You gave me the strength to keep going during the difficult times. Thank you for being there for me and believing in me. VI ~To the stars who listened and to the dreams that were answered~ Sarah J. Maas VII VIII Summary The intestinal microbiota consists of numerous and diverse microbes forming a dynamic ecosystem in close association with the host. One of the many functions of the microbiota is the colonization resistance against intestinal pathogens. Alterations in the composition of the microbiota, for example caused by antibiotics, may cause the loss of colonization resistance, making the host vulnerable towards infections, e.g. with Clostridioides difficile. C. difficile is a spore-forming anaerobic bacterium which can cause severe diarrhea and life-threatening complications in infected individuals. In many developed countries, C. difficile infection is now a major cause of antibiotic-related nosocomial infections. The disease affects mostly elderly individuals. Antibiotics are the standard treatment, however, up to 30% of the patients are suffering from recurrent C. difficile infections. Transfer of fecal matter from a healthy individual to the patient (fecal transplant) is able to cure these infections. Recent studies have demonstrated that the conversion of primary to secondary bile acids by specific commensal bacteria is important for this colonization resistance, but further evidence suggested that the restoration of the secondary bile acid production may not be sufficient for complete protection against this pathogen. In the present study, the effect of the microbiota on C. difficile infection has been explored. Therefore, a C. difficile mouse model has been established initially by exploring the effect of different ages and microbiota compositions on the severity of C. difficile infections. Second, the effect of specific mutations in the genome of C. difficile on the ability to colonize mice and to produce spores has been examined. Third, the inhibitory effect of specifically isolated commensal bacteria of the microbiota of resistant mouse models on C. difficile infections has been explored in depth in order to create a consortium of bacteria that protects the host against C. difficile. Our findings confirm that the age of the mice, comparable as in humans, is important for the severity of the disease of mice. They also confirm that secondary bile acids are indeed important to protect the host against C. difficile infections. However, in our model, adding a secondary bile acid producer to the microbiota is not sufficient for complete protection of the mice, but that together with other commensal bacteria, secondary bile acid producing bacteria are able to provide complete resistance against C. difficile induced pathogenesis. IX Zusammenfassung Die intestinale Mikrobiota bezeichnet ein komplexes Ökosystem aus zahlreichen und diversen Mikroorganismen, welches in enger Verbindung mit dem Wirt steht. Eine Hauptfunktion der Mikrobiota stellt die Besiedelungsresistenz gegen intestinale Pathogene dar. Veränderungen in der Zusammensetzung, zum Beispiel durch den Einsatz von Antibiotika, kann zum Verlust der Besiedelungsresistenz führen und den Wirt anfällig für Infektionen, mit z.B. Clostridioides difficile machen. C. difficile ist ein sporenbildendes, anaerobes Bakterium, welches besonders in immunsupprimierten und älteren Individuen schwere Durchfälle, bis hin zu lebensbedrohlichen Komplikationen führen kann. In Industrieländern ist C. difficile der häufigste Erreger nosokomialer und Antibiotika- assoziierter Durchfallerkrankungen. Nach Standardtherapie mit Antibiotika leiden bis zu 30% der Patienten an wiederkehrenden C. difficile Infektionen. Eine wirkungsvolle Alternativbehandlung stellen Stuhltransfers dar, bei der Bakterien gesunder Person auf den Patienten übertragen werden. Studien haben belegt, dass die Umwandlung von primären zu sekundären Gallensäuren durch spezifische Bakterien ein wichtiger Faktor für die Besiedelungsresistenz gegen C. difficile darstellt, dieser allein aber nicht ausreichend ist, um einen kompletten Schutz
Recommended publications
  • An E Cient System for Intestinal On-Site Butyrate Production Using

    An E Cient System for Intestinal On-Site Butyrate Production Using

    An Ecient System for Intestinal On-site Butyrate Production Using Novel Microbiome-Derived Esterases Dah Hyun Jung Yonsei University College of Medicine Ji Hyun Yong Yonsei University College of Medicine Wontae Hwang Yonsei University College of Medicine Sang Sun Yoon ( [email protected] ) Yonsei University College of Medicine Research Keywords: tributyrin, butyrate, esterase, prodrug, microbiome, metagenomic library, colitis, inammatory bowel disease (IBD), Bacteroidales, Clostridiales Posted Date: November 25th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-112971/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Version of Record: A version of this preprint was published on March 6th, 2021. See the published version at https://doi.org/10.1186/s13036-021-00259-4. Page 1/23 Abstract Short-chain fatty acids, especially butyrate, play benecial roles in sustaining gastrointestinal health. However, due to limitations associated with direct consumption of butyrate, there has been interest in using prodrugs of butyrate. Tributyrin (TB), a triglyceride composed of three butyrate molecules and a glycerol, is a well-studied precursor of butyrate. We screened a metagenome library consisting of 5,760 bacterial articial chromosome clones, with DNA inserts originating from mouse microbiomes, and identied two clones that eciently hydrolyse TB into butyrate. Nucleotide sequence analysis indicated that inserts in these two clones are derived from unknown microbes. BLASTp analysis, however, revealed that each insert contains a gene homologous to acetylesterase or esterase genes, from Clostridium spp. and Bacteroides spp., respectively. Predicted structures of these two proteins both contain serine- histidine-aspartate catalytic triad, highly conserved in the family of esterases.
  • Single-Cell Genomics of Uncultured Bacteria Reveals Dietary Fiber

    Single-Cell Genomics of Uncultured Bacteria Reveals Dietary Fiber

    Chijiiwa et al. Microbiome (2020) 8:5 https://doi.org/10.1186/s40168-019-0779-2 RESEARCH Open Access Single-cell genomics of uncultured bacteria reveals dietary fiber responders in the mouse gut microbiota Rieka Chijiiwa1,2†, Masahito Hosokawa3,4,5*† , Masato Kogawa1,2, Yohei Nishikawa1,2, Keigo Ide1,2, Chikako Sakanashi3, Kai Takahashi1 and Haruko Takeyama1,2,3,4* Abstract: Background: The gut microbiota can have dramatic effects on host metabolism; however, current genomic strategies for uncultured bacteria have several limitations that hinder their ability to identify responders to metabolic changes in the microbiota. In this study, we describe a novel single-cell genomic sequencing technique that can identify metabolic responders at the species level without the need for reference genomes, and apply this method to identify bacterial responders to an inulin-based diet in the mouse gut microbiota. Results: Inulin-feeding changed the mouse fecal microbiome composition to increase Bacteroides spp., resulting in the production of abundant succinate in the mouse intestine. Using our massively parallel single-cell genome sequencing technique, named SAG-gel platform, we obtained 346 single-amplified genomes (SAGs) from mouse gut microbes before and after dietary inulin supplementation. After quality control, the SAGs were classified as 267 bacteria, spanning 2 phyla, 4 classes, 7 orders, and 14 families, and 31 different strains of SAGs were graded as high- and medium-quality draft genomes. From these, we have successfully obtained the genomes of the dominant inulin-responders, Bacteroides spp., and identified their polysaccharide utilization loci and their specific metabolic pathways for succinate production. Conclusions: Our single-cell genomics approach generated a massive amount of SAGs, enabling a functional analysis of uncultured bacteria in the intestinal microbiome.
  • Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice

    Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice

    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.01.183202; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Muribaculaceae genomes assembled from metagenomes suggest genetic drivers of differential response to acarbose treatment in mice Byron J. Smitha,* Richard A. Millerb Thomas M. Schmidta,c,# aDepartment of Ecology & Evolutionary Biology, University of Michigan, Ann Arbor, MI, USA. bDepartment of Pathology and Geriatrics Center, University of Michigan, Ann Arbor, MI, USA. cDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. *Present address: J. David Gladstone Institutes, San Francisco, CA, USA. #Correspondence: [email protected] Running title: Genomes of acarbose-responsive Muribaculaceae Word Count: Abstract: 249 Importance: 149 Manuscript: 6,369 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.01.183202; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 2 Abstract The drug acarbose (ACA) is used to treat diabetes, and, by inhibiting α-amylase in the small intestine, increases the amount of starch entering the lower digestive tract. This results in changes to the composition of the microbiota and their fermentation products. Acarbose also increases longevity in mice, an effect that has been correlated with increased production of the short-chain fatty acids propionate and butyrate.
  • Sequence and Cultivation Study of Muribaculaceae Reveals Novel

    Sequence and Cultivation Study of Muribaculaceae Reveals Novel

    Lagkouvardos et al. Microbiome (2019) 7:28 https://doi.org/10.1186/s40168-019-0637-2 RESEARCH Open Access Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family Ilias Lagkouvardos1,TillR.Lesker2, Thomas C. A. Hitch3, Eric J. C. Gálvez2,NathianaSmit2, Klaus Neuhaus1, Jun Wang4, John F. Baines4,5, Birte Abt6,8,BärbelStecher7,8,JörgOvermann6,8,TillStrowig2* and Thomas Clavel1,3* Abstract Background: Bacteria within family S24-7 (phylum Bacteroidetes) are dominant in the mouse gut microbiota and detected in the intestine of other animals. Because they had not been cultured until recently and the family classification is still ambiguous, interaction with their host was difficult to study and confusion still exists regarding sequence data annotation. Methods: We investigated family S24-7 by combining data from large-scale 16S rRNA gene analysis and from functional and taxonomic studies of metagenomic and cultured species. Results: A total of 685 species was inferred by full-length 16S rRNA gene sequence clustering. While many species could not be assigned ecological habitats (93,045 samples analyzed), the mouse was the most commonly identified host (average of 20% relative abundance and nine co-occurring species). Shotgun metagenomics allowed reconstruction of 59 molecular species, of which 34 were representative of the 16S rRNA gene-derived species clusters. In addition, cultivation efforts allowed isolating five strains representing three species, including two novel taxa. Genome analysis revealed that S24-7 spp. are functionally distinct from neighboring families and versatile with respect to complex carbohydrate degradation. Conclusions: We provide novel data on the diversity, ecology, and description of bacterial family S24-7, for which the name Muribaculaceae is proposed.
  • Nature Communications

    Nature Communications

    ARTICLE https://doi.org/10.1038/s41467-020-18928-1 OPEN Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization Fátima C. Pereira 1, Kenneth Wasmund1, Iva Cobankovic2, Nico Jehmlich 3, Craig W. Herbold1, Kang Soo Lee 4,5, Barbara Sziranyi1, Cornelia Vesely6, Thomas Decker 7, Roman Stocker 4,5, ✉ Benedikt Warth 2, Martin von Bergen3, Michael Wagner1,8 & David Berry 1,9 1234567890():,; Many intestinal pathogens, including Clostridioides difficile, use mucus-derived sugars as crucial nutrients in the gut. Commensals that compete with pathogens for such nutrients are therefore ecological gatekeepers in healthy guts, and are attractive candidates for therapeutic interventions. Nevertheless, there is a poor understanding of which commensals use mucin- derived sugars in situ as well as their potential to impede pathogen colonization. Here, we identify mouse gut commensals that utilize mucus-derived monosaccharides within complex communities using single-cell stable isotope probing, Raman-activated cell sorting and mini- metagenomics. Sequencing of cell-sorted fractions reveals members of the underexplored family Muribaculaceae as major mucin monosaccharide foragers, followed by members of Lachnospiraceae, Rikenellaceae, and Bacteroidaceae families. Using this information, we assembled a five-member consortium of sialic acid and N-acetylglucosamine utilizers that impedes C. difficile’s access to these mucosal sugars and impairs pathogen colonization in antibiotic-treated mice. Our findings underscore the value of targeted approaches to identify organisms utilizing key nutrients and to rationally design effective probiotic mixtures. 1 University of Vienna, Centre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, Althanstrasse 14, 1090 Vienna, Austria.
  • Changes in the Gut Microbiota and Fermentation Products Associated with Enhanced Longevity in Acarbose-Treated Mice

    Changes in the Gut Microbiota and Fermentation Products Associated with Enhanced Longevity in Acarbose-Treated Mice

    bioRxiv preprint doi: https://doi.org/10.1101/311456; this version posted April 30, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Smith et al. RESEARCH Changes in the gut microbiota and fermentation products associated with enhanced longevity in acarbose-treated mice. Byron J Smith1, Richard A Miller2, Aaron C Ericsson3, David C Harrison4, Randy Strong5,6,7 and Thomas M Schmidt1,8* *Correspondence: [email protected] 8Department of Internal Medicine, University of Michigan, 48109 Ann Arbor, MI, USA Abstract Full list of author information is α available at the end of the article Background: Treatment with the -glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specificity ofthe lifespan effect. By inhibiting host digestion, acarbose increases the flux ofstarch to the lower digestive system, resulting in changes to the gut microbiota and their fermentation products. Given the documented health benefits of short-chain fatty acids (SCFAs), the dominant products of starch fermentation by gut bacteria, this secondary effect of acarbose could contribute to increased longevity in mice. To explore this hypothesis, we compared the fecal microbiome of mice treated with acarbose to control mice at three independent study sites. Results: Microbial communities and the concentrations of SCFAs in the feces of mice treated with acarbose were notably different from those of control mice.
  • Integrated Analysis of the Gut Microbiota and Their Fermentation Products in Mice Treated with the Longevity Enhancing Drug Acarbose

    Integrated Analysis of the Gut Microbiota and Their Fermentation Products in Mice Treated with the Longevity Enhancing Drug Acarbose

    Integrated Analysis of the Gut Microbiota and Their Fermentation Products in Mice Treated with the Longevity Enhancing Drug Acarbose by Byron J. Smith A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Ecology and Evolutionary Biology) in the University of Michigan 2019 Doctoral Committee: Professor Thomas M. Schmidt, Chair Professor Gregory J. Dick Professor Meghan A. Duffy Professor Aaron A. King Byron J. Smith [email protected] ORCID iD: 0000-0002-0182-404X © Byron J. Smith 2019 ACKNOWLEDGMENTS This work is supported by The Glenn Foundation for Medical Research, the Host Microbiome Initiative at the University of Michigan, and an Integrated Training in Microbial Systems fellowship. Additional funding came from the Department of Ecology and Evolutionary Biology at the University of Michi- gan. I want to thank my advisor, Tom, for his wonderful mentorship over the entirety of my PhD. His advising style—usually hands off, and often more of a collaborator than a director of his students’ work—has been integral to my graduate school experience. Given the freedom and time to explore the field on my own, I have developed more as an individual scientist than I would have imagined possible. I know that I was not always the easiest trainee to work with, but he has been patient throughout. Similarly, I need to thank the myriad other mentors, including the members of my committee, whose feedback and optimism have been a vital resource. Aaron, Greg, and Meg have each had important impacts on not only my science, but also how I think about my PhD and my future career.
  • Changes in the Gut Microbiome and Fermentation Products Concurrent with Enhanced Longevity in Acarbose-Treated Mice

    Changes in the Gut Microbiome and Fermentation Products Concurrent with Enhanced Longevity in Acarbose-Treated Mice

    The Jackson Laboratory The Mouseion at the JAXlibrary Faculty Research 2019 Faculty Research 6-13-2019 Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice. Byron J Smith Richard A Miller Aaron C Ericsson David E Harrison Randy Strong See next page for additional authors Follow this and additional works at: https://mouseion.jax.org/stfb2019 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons Authors Byron J Smith, Richard A Miller, Aaron C Ericsson, David E Harrison, Randy Strong, and Thomas M Schmidt Smith et al. BMC Microbiology (2019) 19:130 https://doi.org/10.1186/s12866-019-1494-7 RESEARCH ARTICLE Open Access Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice Byron J Smith1, Richard A Miller2, Aaron C Ericsson3,DavidCHarrison4, Randy Strong5,6,7 and Thomas M Schmidt1,8* Abstract Background: Treatment with the α-glucosidase inhibitor acarbose increases median lifespan by approximately 20% in male mice and 5% in females. This longevity extension differs from dietary restriction based on a number of features, including the relatively small effects on weight and the sex-specificity of the lifespan effect. By inhibiting host digestion, acarbose increases the flux of starch to the lower digestive system, resulting in changes to the gut microbiota and their fermentation products. Given the documented health benefits of short-chain fatty acids (SCFAs), the dominant products of starch fermentation by gut bacteria, this secondary effect of acarbose could contribute to increased longevity in mice. To explore this hypothesis, we compared the fecal microbiome of mice treated with acarbose to control mice at three independent study sites.